Kinuko Tajima

1.3k total citations
51 papers, 906 citations indexed

About

Kinuko Tajima is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kinuko Tajima has authored 51 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 21 papers in Oncology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kinuko Tajima's work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Lymphoblastic Leukemia research (13 papers) and Acute Myeloid Leukemia Research (12 papers). Kinuko Tajima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Acute Lymphoblastic Leukemia research (13 papers) and Acute Myeloid Leukemia Research (12 papers). Kinuko Tajima collaborates with scholars based in Japan, United States and United Kingdom. Kinuko Tajima's co-authors include Yoshihiro Matsuno, Kanji Nagai, Hisao Asamura, Takeshi Inoue, Masayuki Noguchi, Toru Kameya, Ken Nakagawa, Tomoyuki Yokose, Shi-Xu Jiang and Yuichi Ishikawa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Kinuko Tajima

47 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kinuko Tajima Japan	16	532	381	286	173	145	51	906
Elisabetta Todisco Italy	19	487 0.9×	136 0.4×	410 1.4×	90 0.5×	125 0.9×	56	1.1k
Toshiki Yamada Japan	18	336 0.6×	174 0.5×	441 1.5×	96 0.6×	86 0.6×	61	1.1k
Nobuhiko Uoshima Japan	15	311 0.6×	200 0.5×	336 1.2×	71 0.4×	53 0.4×	58	839
Pascale Schneider France	14	166 0.3×	151 0.4×	252 0.9×	169 1.0×	113 0.8×	58	921
BJ Bolwell United States	13	331 0.6×	109 0.3×	383 1.3×	111 0.6×	34 0.2×	19	685
Mireia Morgades Spain	13	372 0.7×	78 0.2×	310 1.1×	284 1.6×	81 0.6×	45	727
Kenji Fukuno Japan	13	229 0.4×	110 0.3×	262 0.9×	68 0.4×	65 0.4×	31	667
Abraham S. Kanate United States	17	376 0.7×	118 0.3×	371 1.3×	103 0.6×	24 0.2×	61	815
A. H. Goldstone United Kingdom	16	318 0.6×	103 0.3×	397 1.4×	122 0.7×	64 0.4×	33	921
Roni Tamari United States	18	278 0.5×	176 0.5×	601 2.1×	127 0.7×	30 0.2×	98	977

Countries citing papers authored by Kinuko Tajima

Since Specialization

Citations

This map shows the geographic impact of Kinuko Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinuko Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinuko Tajima more than expected).

Fields of papers citing papers by Kinuko Tajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kinuko Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinuko Tajima. The network helps show where Kinuko Tajima may publish in the future.

Co-authorship network of co-authors of Kinuko Tajima

This figure shows the co-authorship network connecting the top 25 collaborators of Kinuko Tajima. A scholar is included among the top collaborators of Kinuko Tajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinuko Tajima. Kinuko Tajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ito, Ayumu, Shigehisa Kitano, Kinuko Tajima, et al.. (2019). Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation. International Journal of Hematology. 111(1). 120–130. 7 indexed citations

Ochi, Kiyosumi, Shigeo Fuji, Kuniko Takano, et al.. (2018). The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia. Bone Marrow Transplantation. 53(8). 1019–1029. 5 indexed citations

Okinaka, Keiji, Yukihiro Akeda, Saiko Kurosawa, et al.. (2017). Pneumococcal polysaccharide vaccination in allogeneic hematopoietic stem cell transplantation recipients: a prospective single-center study. Microbes and Infection. 19(11). 553–559. 3 indexed citations

Fuji, Shigeo, Kinuko Tajima, Takashi Tanaka, et al.. (2017). Clinical Utility of Wilms' Tumor 1 Monitoring in Patients with Myeloid Malignancy and Prior Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(10). 1780–1787. 12 indexed citations

Kawashima, Ichiro, Yoshihiro Inamoto, Akiko Miyagi Maeshima, et al.. (2017). Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(2). 294–300. 21 indexed citations

Inamoto, Yoshihiro, Kinuko Tajima, Takashi Tanaka, et al.. (2016). Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(6). 1102–1107. 33 indexed citations

Maruyama, Dai, Akiko Miyagi Maeshima, Junko Nomoto, et al.. (2016). Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era. Blood Cancer Journal. 6(9). e477–e477. 5 indexed citations

Fuji, Shigeo, Yoshihiro Inamoto, Kinuko Tajima, et al.. (2016). Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation. International Journal of Hematology. 103(4). 453–460. 28 indexed citations

Maruyama, Dai, Akiko Miyagi Maeshima, Shinichi Makita, et al.. (2016). Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Annals of Hematology. 95(12). 2017–2022. 18 indexed citations

10.

Tanaka, Yoshinori, Saiko Kurosawa, Kinuko Tajima, et al.. (2016). Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 51(4). 553–559. 45 indexed citations

11.

Tada, Kohei, Sung‐Won Kim, Yoshitaka Asakura, et al.. (2012). Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B‐cell lymphoma associated with follicular lymphoma, or de novo diffuse large B‐cell lymphoma. American Journal of Hematology. 87(8). 770–775. 9 indexed citations

12.

Kurosawa, Saiko, Takahiro Fukuda, Kinuko Tajima, et al.. (2009). Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation. American Journal of Hematology. 84(12). 815–820. 17 indexed citations

13.

Saito, Bungo, Takahiro Fukuda, Hiroki Yokoyama, et al.. (2008). Impact of T Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen. Biology of Blood and Marrow Transplantation. 14(10). 1148–1155. 39 indexed citations

14.

Tobinai, Kensei, Kunihiko Takeyama, Keiko Aikawa, et al.. (2007). Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004. Cancer Science. 98(9). 1350–1357. 8 indexed citations

15.

Tanimoto, Tetsuya, Takuhiro Yamaguchi, Yuji Tanaka, et al.. (2004). Comparative analysis of clinical outcomes after allogeneic bone marrow transplantationversusperipheral blood stem cell transplantation from a related donor in Japanese patients. British Journal of Haematology. 125(4). 480–493. 27 indexed citations

16.

Takenaka, T, S Shirakawa, C Mikuni, et al.. (1999). Alternating Combination Chemotherapy COP (Cyclophosphamide, Vincristine, Prednisone) and MP (Melphalan, Prednisone) in Multiple Myeloma: a Multicenter Phase II Study (JCOG8906). Japanese Journal of Clinical Oncology. 29(10). 485–489. 3 indexed citations

17.

Katsumata, Noriyuki, Yoshihiro Matsuno, H. Nakayama, et al.. (1996). Prognostic Factors and a Predictive Model of Follicular Lymphoma: A 25-year Study at a Single Institution in Japan. Japanese Journal of Clinical Oncology. 26(6). 445–454. 13 indexed citations

18.

Ohmatsu, H., Tomohide Tamura, Hiroshi Kunikane, et al.. (1994). A Randomized Cross‐over Study of High‐dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High‐dose Cisplatin. Japanese Journal of Cancer Research. 85(11). 1151–1158. 14 indexed citations

19.

Shimoyama, M, Atsushi Oyama, Kinuko Tajima, et al.. (1993). Differences in Clinicopathological Characteristics and Major Prognostic Factors between B-Lymphoma and Peripheral T-lymphoma Excluding Adult T-cell Leukemia/lymphoma. Leukemia & lymphoma. 10(4-5). 335–342. 16 indexed citations

20.

Fukutani, Miki, Kinuko Tajima, Yuka Tanaka, et al.. (1992). Feasibility Study on Quality-of-life Questionnaires for Patients with Advanced Lung Cancer. Japanese Journal of Clinical Oncology. 22(3). 185–93. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact